Physician Issues | Addiction Professional Magazine Skip to content Skip to navigation

Physician Issues

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

Studies capture challenges in reaching rescued patients

October 30, 2017  |  Gary A. Enos, Editor
article
Research released today at the American College of Emergency Physicians' annual meeting demonstrates the complexities of achieving positive outcomes with patients rescued from an opioid overdose.

Insurers track adherence to CDC opioid guidelines

October 23, 2017  |  Julie Miller, Editor in Chief
article
Data is the one thing that managed care has in spades. And now the health plan industry is using that data to help prevent opioid misuse.

Lakeview Health launches pain recovery program

October 11, 2017  |  Gary A. Enos, Editor
news
The Florida facility's new service for patients experiencing addiction and chronic pain will include a process group focused on pain recovery and peer support.

Hospitalized overdose patients sicker, costlier, more likely to die

August 29, 2017  |  Gary A. Enos, Editor
article
Research findings released this week point to growing critical care needs for opioid overdose victims, attributable in part to the transition to heroin.

Study examines opioid drug company payments to physicians

August 25, 2017  |  Gary A. Enos, Editor
news
A new study finds that one in five family physicians accepted some form of drug company payment related to opioid pharmaceuticals.

Missouri sets up PDMP at last, but with caveats

August 10, 2017  |  Julie Miller, Editor in Chief
article
Under Missouri's statewide prescription drug monitoring program, clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Predictive testing company under fraud investigation

June 12, 2017  |  Gary A. Enos, Editor
news
Proove Biosciences, which markets technology designed to predict a patient's response to opioid dependence medications and other drugs, has had its office headquarters raided in an apparent healthcare fraud probe.

Pages

Subscribe to Physician Issues